Gerard Drewes

Heidelberg, BW 69117, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Correction: Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells.

Correction: Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells.

Journal: eLife

Published: November 14, 2023

Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.

Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.

Journal: Nature

Published: July 04, 2023

Mapping the functional impact of non-coding regulatory elements in primary T cells through single-cell CRISPR screens.

Mapping the functional impact of non-coding regulatory elements in primary T cells through single-cell CRISPR screens.

Journal: Genome biology

Published: June 18, 2023

1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in Mycobacterium tuberculosis.

1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in Mycobacterium tuberculosis.

Journal: ACS infectious diseases

Published: November 03, 2022

The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages.

The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages.

Journal: Science translational medicine

Published: October 19, 2022

Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency.

Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: September 08, 2022

Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells.

Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells.

Journal: eLife

Published: May 13, 2022

The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis.

The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis.

Journal: Science translational medicine

Published: May 04, 2022

Converging roles of PSENEN/PEN2 and CLN3 in the autophagy-lysosome system.

Converging roles of PSENEN/PEN2 and CLN3 in the autophagy-lysosome system.

Journal: Autophagy

Published: December 29, 2021

Patient-derived gene and protein expression signatures of NGLY1 deficiency.

Patient-derived gene and protein expression signatures of NGLY1 deficiency.

Journal: Journal of biochemistry

Published: August 09, 2021

A Tandem Guide RNA-Based Strategy for Efficient CRISPR Gene Editing of Cell Populations with Low Heterogeneity of Edited Alleles.

A Tandem Guide RNA-Based Strategy for Efficient CRISPR Gene Editing of Cell Populations with Low Heterogeneity of Edited Alleles.

Journal: The CRISPR journal

Published: April 22, 2020

Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell Lines.

Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell Lines.

Journal: G3 (Bethesda, Md.)

Published: April 09, 2020

Showing 1-12 of 65

Last Updated: 09/26/2026